close

Enter

Log in using OpenID

PDF File - 日本エイズ学会

embedDownload
ῌ,**1 The Japanese Society for AIDS Research
The Journal of AIDS Research
HIV HIV ῌAIDS + + , +
+
,
! : !"# HIV $%&'()
!*+,-. /
"# : ,**+ + 012 ,**/ +, 03 / 4! 56789 HIV :;<=
;> [email protected] HIV $%>ῌAIDS C> ,+ DE/
$% : C>F'GHI -,.1 J K ,* LK + M8/ N HIV $%>
I ++ -*.3 JM8/ 38 AIDS C>I +* -..1 JOPPHQR1M8/ C>
'G CD. KSTHI +3,ῌml U '78 AIDS C>!V O -.ῌml O
!W7,+8/ HIV $%A IXYQ!Z[ "K4\]Q +- ^K4\]Q - N#$_Q / M8/ `12%&abC>I ++ 'U c(Q / Ode)f *
+,+g,Q . M8/ 389 HIV :;<=;>TIhij7,+ Q K>Ik2lm1M8/
&' : C>./O7, $%78Ono2l &Ipmf ,q$
%>Q!%r +Ist!0+ab='. &Q)+/ 717uv$%>T
ijD127,"f34QU 38F'G AIDS epmfm+wO12 HIV :;<
DxU5?yz wOQ{4 Ono2l /
()*)+ : HIV :;< AIDS C> 67|} 3 : +/-῍+/1 ,**1
,-.
"#/0
HIV $%&I~Q€ij7,"U+, , N‚
,**+ + 012 ,**/ +, 03 / 4D9<E
!*+,eT)f-yl,+ / 717N8ƒIX
O7 N4!56789 HIV :;<=
9<-, . P +g cm„,q!"#
;> "[email protected]> ,+ ‡B + D”•78/
-
U/, 0 :;!"# ()I1m2…7e
HIV $%>O AIDS C>'I–—CD˜8ƒ
21Im+/
™Y|Q-78'š›!›œ81/
I +33. ++ 0!Fk,!
-<yl8†=
/ ‡ˆ>
+30 ? I q ‡ˆ> 02 ? 0
D‰O7, +* QŠ<yl HIV $%&'!
‹~M,+ /
$
%
+1 2345! HIV 67
567,+
HIV-+,, :žŸ ¡¢£;<
I ¤¥ž¦§¨E ‡©ª«¬¨Z ©ªžŸ uŒ @q ‡ˆ> .1 ? ! !"+, ,**+
¢ῌHIV-+ῌ, !x ­F;< / I HIV :
+ 012 ,**/ +, 03 / 4!AB78 HIV $
;<®G>!7,¯!;<6!°±²D7,+
%>ῌAIDS C> ‡ŽW C> O+‘ ,+ D‰!
HIV $%&'()D3Ok8A’n“Djo
,-. /
/ ,**+ I 1 ³ ,**, I ++ ³ ,**- I +1 ³ ,**.
I ,* ³ ,**/ I ,0 ³U =;TIhij7,
+ / +…le°±I´KU K>IAB7,+m
+ ൠ+/
,1 7
>JKº : ‡ »1*+῍*+3, @q¼L /11 FAX : *20῍.0.῍++3.
,**0 1 0 -+ 6=M ; ,**1 - 0 / 6=N
HIV $%>O AIDS C>TDµ , !¶./ ·H!I8
QU ¸;mij¹ƒI¶7,+m+/
+/-
‡ 0- H Tokunaga et al : Present State of HIV Antibody Survey Subjects and HIV/AIDS Patient Management
- +
-
,,!/. HIV " ++ /,..῍
-,.1
-*.3
,,!/. # ,*
AIDS ,+ +* /
cdefghih/j+klmnopqlrh CMV
01j#s - +<=H
+ tuv2
w# , CMV ": 01j xyzm{|th
$ - %
AIDS +* .1.0῍ : m}~z€3: (‚ƒ'„…†:#s +
-..1
$ .
,0!/+ & -*
$ - CD. '() +3,ῌml ,
0 !//+ * AIDS +
n,0 -
45# / +<=H
+‡neˆ‰6 Š7
. -.ῌml 2!1/ +/01
'210
8 ‹Œ9tvŽ: :;; <=‘78#
'# ,* 3'# + 45675
s , B ’Šj# + $ /
+89:;60# 1 +<=& >?
1
!"#$ Highly Active Anti-retroviral Therapy
@AB*"#C+8
:D#
HAART
/ + %
EFGHI ++
HAART >O“” key drug +0•–—˜™
* J # / +<=& !10"K## . š EFV ?1
=# 1 +<=& ›1
+ LMN$O9+EFG%&P# 3 pœ˜r ῌ ym˜[email protected] LPV ῌ RTV # / EFP# 1 QH
%
žŸA EFV¡¢£v -
HIV .
TC¡¤¥¦˜r TDF >O“”§9 + B
'R#(STUV* )'W*X# +- Y'W*
X# - +# / )'W":Z[
0 MSM Men who have Sex with Men 9 %
+ / ,\]-^.'W8_`a19 b(
' +
' F±
+
,
.
/
0
1
2
3
+*
++
+,
++.
+/
+0
+1
+2
+3
,*
,+
,0
-,
/+
-/
-1
.*
,/
,0
,/
/.
,0
,,
-1
-*
,1
-,
,0
.0
,/
,3
-0
3
EF
J
EF
EF
L´
EF
EF
"K
EF
µM
"K
J
J
EF
"K
"K
J
J
EF
EF
EF
:;
0. %
&
EFG%&P+1«$#P9 +33. ++ ¬
HIV "ῌAIDS E­®¯°
G:
HIV 3:
¶·¸¹
CMV 01j
ºN¸¹
/j
cdefghih/j
CMV 01j
cdefghih/j
CMV ":
HTLV-+ '
:;;
:;;
‡neˆŠ78
‡neˆŠ78
xyzm{|th3j xyzm{|th3j
tuv2w
tuv2w
tuv2w
-
-
‡neˆ‰6
:;;
"O:;
P'Qƒ»:
:;;
HIV : Human Immunodeficiency Virus
+/.
+ ¨9C#©D+80ª019 ,
H
CD. ) HIV-RNA
²+*.
ῌml
copyῌml
++
++
-.
.2
1/
.0.
.-1
+,-2,
03
.**
,
2,
-
-
+0---.1
++2
//+
+42
,/4/
,+/
1/
1/
*4+.
,42
*4/,
-42
+04*
*4,3
043
-14*
-
-
*4.1
-4/
-4,
04,
*4.0
AIDS HAART
I
I
¼I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
CMV : Cytomegalovirus HTLV-+ : Human T-Lymphotropic Virus Type-+
"
³J
°
K
Y'W
)'W
-
)'W
Y'W
)'W
)'W
)'W
)'W
-
-
)'W
Y'W
)'W
-
-
)'W
)'W
)'W
)'W
)'W
R,
R,
R,
R,
R,
R,
R,
R,
R,
+
R,
R,
+
R,
+R
+
R,
R,
R,
R,
R,
The Journal of AIDS Research Vol. 3
ῌ +
ῌ ,
No. ,
,**1
UV{iu HIV |}~~%ºf
UV HIV EF!ῌAIDS
!%ºf
HIV EF# AIDS
!GHI # GHI J
KLMN# OCPQRS?T"A
BC?D UV !WX"# YZ#
=[?\=]^EF !(_`abc6d
efd# gh AIDS ijkl# =]^m
HIVῌAIDS nopC# gOqpCh_rs
tpC(;<uvOw HIV EFxyz(
wD# {iu HIV |}~J€n‚
ƒ~! 2+ „"# …(†?O# ‡
ˆ"eEF3(wD‰"# PŠ‹%
wNC? Œ‚Ž8e !%/0+' €
j# hp=]^mst !(‘’j
ON
“U”•(w PU"
! % ( P Š ‹ ? ”# – ‰
ῌ -
HIV EF!ῌAIDS
!»¼
!a—…˜™y6
HAART š›?\M"šœwO"
B? OCžŸ€ ¡j¢£"¤¥
,**+ ¦§n¨©ª«¬z€­”®d¯2'# °
/ ,+ ?±4€¤²•(w pst³w"st
!"# $%
&.2ῌ' ( ,* )*# +,-./012345
6789:+' ;<=>[email protected]"ABC?D
´±4µ¶€·¸jON–w
he HIV EFj‰(‘’j¹…
+//
& 0/ '
H Tokunaga et al : Present State of HIV Antibody Survey Subjects and HIV/AIDS Patient Management
ΐ .
ΐ /
AIDS GB’y¦QFG
῔ ,
HIV BῌAIDS GB’y¦QFGuv
%kJ. HAART R§*
Back bone drugs
Key drugs
¨S©ªTU«V
®W¯°
X2
+
,
/
/
/
.
,
,
+
+
+
AZT
-TC
AZT/-TC
ia¬13­U«V
ABC
±
TDF
EFV
±
±
±
±
±
±
±
±
RTV
±
±
±
±
±
±
±
LPV/RTV
±
±
±
ATV
±
AZT : 9²`98 -TC : h³`98 AZTῌ-TC : 9²`98ῌh³`98 ABC : 147f´ TDF : ¬µ¶f´
EFV : !·¸fe8¹ ATV : 1_º»f´ LPVῌRTV : a¼»f´ῌXP»f´ RTV : XP»f´
HIV 7|}8 9:;)<~$
%0+
HIV / /o;€=‚60>ƒ„
!"#$
%& HIV '(
E+…
3, +*
)*+ , / -./0
1234 56789: ; B <=>?
ῌ῏῎῍
@A HIV BC+D%
†‡ˆ!"#$
%‰S%Š'!‹
+EFG'.H HIV '
. [email protected] Œk;xA'B
IJ0KLE
.0L EŽk‘C
%D& HIV MB. NO3
PQRS !"T'U#.0L $
ῒῑ : $D6’ †‡ HIV 6“bP”3W
VWX3Y8Z[\'%&. ,]'
•–BDED—˜F—™š'› œ
.^!V_8`abP( c)defg* h`iabP
.G.Hž ’%D ,**1 I . Ÿ†‡ˆ
+
j+ RT-PCR ('%kJ. l,-$
Dmn./o0'p1. qr HIV s23t4 (uvwx.yzy
7^8{X8Z05#!"#6
+/0
c 00
’y!"# 6<~$
%J/)
῕
+
ῐ
¡KLMN!"#O¢£¤¥ : P8 +0 I!"#K
The Journal of AIDS Research Vol. 3
,**/.
No. ,
,**1
< ! : klmnop'()*+,-. HIVῌ
, Yoshikura H : HIV transmission webs : HIV infection
trends in Japan in +323ῌ,**.. Jpn J Infect Dis /2 : S+3ῌ
AIDS /῏0&qrs tuvwx*y2 3"#$
456 2 : -.ῌ.* ,**0.
1 zFῒ{|"#$}~5 : €#‚ƒ„&…†
,+, ,**/.
- ῎ ῔ ῌ ! : "#$%
& HIV STUῌAIDS \‡ˆ‰ +333.
2 :% Š‹Œ D:῕% ῔:d Ž
῏&'()*+,-. HIVῌAIDS &/῏012 3
‘:’ “῔” •–— : `˜ HIV \῏&™š
"#$456 . : 3+ῌ3/ ,**,.
›œ†ža`.Ÿ& ¡¢£ ¤¥f"#$'(
. ῎ ῌ ῔ ! : "#$'
()*+,-. HIVῌAIDS &/῏01&782 3
"#$456 0 : -+ῌ-0 ,**..
/ 9:ΐ 3;ῌ< =>? @A BC
)*&P῏¦§0+¨©.ªƒ«€¬­®&¯°2 3
"#$456 0 : ./* ,**..
3 •–— ±²< ³9´µ : ¶·¸›&¹®ῌ῍º
»2 3"#$456 0 : ++2ῌ+,, ,**..
+* Watanabe T, Nakamura Y, Kidokoro T, Shimazaki E,
D
EF G:HI JKL : MNO<PQR4)*
Hasegawa Y, Tamura Y, Tanihara S, Hashimoto S : The
+,-. HIV STUῑ ,0 ῑ&ῐVWXY,Z[\῏
characteristics of people requesting HIV antibody tests at
]^+_`a2 3"#$456 . : +1ῌ,, ,**,.
public health centers in Japan. Journal of Epidemiology
0 bcde fIgh i:j
+. : +*ῌ+0, ,**..
Present State of HIV Antibody Survey Subjects and HIV/AIDS Patient
Management at Kawasaki Medical School Hospital
Hirotoshi TOKUNAGA+, Hideho WADA+, Osamu YAMADA, and Takashi SUGIHARA+
+
Division of Hematology, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan
,
Graduate School of Medicine, Yamaguchi University, Ube, Japan
Objective : To characterize the state of management of HIV/AIDS patients at Kawasaki
Medical School Hospital, which is a local core hospital for AIDS treatment in Okayama
Prefecture.
Methods : The subjects of an HIV antibody survey and ,+ HIV/AIDS patients treated at
our hospital between January ,**+ and December ,**/ were investigated.
Results : The patients consisted of ,* men and one woman with a mean age of -,.1 years
at initial presentation. There were ++ HIV-infected persons with a mean age of -*.3 years.
Ten of these patients developed AIDS, and they had a slightly higher mean age of -..1 years
at initial presentation. The mean CD.-positive cell count of the ,+ patients was +3,/ml at
diagnosis. The six patients who were diagnosed with AIDS in our hospital had a mean CD.positive cell count of only -./ml. All ,+ patients were infected with HIV through routes other
than blood products, including +- patients infected through homosexual intercourse, three
through heterosexual intercourse, and five via unknown routes. Eleven patients were referred
from other prefectures, including five from Osaka and four from Tokyo. The number of the
subjects of an HIV antibody survey increased in five years, but there were no positive patients.
Discussion : The main characteristic of HIV patients at this local core model hospital was
that only a few of them were infected in Okayama Prefecture. Many of them were referred
from larger cities outside the prefecture after they were transferred by their companies or
returned home. However, it is expected that the number of patients infected within Okayama
Prefecture will increase in the future. There is also an increasing trend for patients to develop
AIDS before initial presentation. Therefore, it is important to increase the performance of
HIV antibody testing.
Key words : local core model hospital for AIDS treatment, HIV antibody survey, AIDS
patients, Okayama Prefecture
+/1
¼ 01 
Author
Document
Category
Uncategorized
Views
17
File Size
907 KB
Tags
1/--pages
Report inappropriate content